Your Messages Inbox
Your Article Summary
See Latest ArticlesCovidien Announces License Rights Acquisition Agreement
Covidien, 07/15/09
Covidien , a leading global provider of healthcare products, announced that one of its Pharmaceutical Products subsidiaries has acquired the licensing rights to drug candidate Exalgo, Extended-Release Tablets, a formulation of an opioid analgesic from Neuromed Development Inc., a subsidiary of Neuromed Pharmaceuticals Ltd. The agreement is aimed at expanding Covidien's presence in the branded pain management market.
Today in M&A/Partnerships...keeping you current
Receive free subspecialty "5-minute updates" via email
GSK completes extension of strategic collaboration with Aspen
GlaxoSmithKline, 12/02/09
Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
Novartis, 11/25/09
Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread(R) for Chronic Hepatitis B in Key Asian Countries
Gilead, 11/25/09
Article Search
Sponsor